Advertisement

Topics

Companies Related to "University Eastern Finland Release Antiulcer Drugs Increase Risk" [Most Relevant Company Matches] RSS

23:00 EST 21st November 2017 | BioPortfolio

Here are the most relevant search results for "University Eastern Finland Release Antiulcer Drugs Increase Risk" found in our extensive corporate database of over 50,000 company records.

Showing "University Eastern Finland Release Antiulcer Drugs Increase Risk" Companies 1–25 of 4,500+

Monday 20th November 2017

resTORbio, Inc.

resTORbio, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. resTORbio’s lead program is targeting the target of rapamycin complex 1 (TORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caus...


Thursday 16th November 2017

New York University Stern School of Business

New York University Stern School of Business, located in the heart of Greenwich Village, is one of the nation’s premier management education schools and research centers. NYU Stern, whose faculty includes three Nobel Laureates in Economics, offers a broad portfolio of programs at the graduate and undergraduate levels, all of them enriched by the dynam...

Modulated Imaging, Inc.

Modulated Imaging, Inc. was founded in 2008 to develop light based imaging technology for preventing, diagnosing, and curing medical conditions. The company’s innovative science is designed to profoundly increase quality-of-life. Learn more at www.modulatedimaging.com.


Wednesday 15th November 2017

Inozyme Pharma, Inc.

Inozyme Pharma is a biotechnology company committed to developing novel medicines for the treatment of rare diseases characterized by mineral imbalances, which lead to over calcification of soft tissues and under mineralization of bone. The company was founded in 2016 with technology licensed from Yale University.

Tuesday 14th November 2017

Exicure, Inc.

Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Exicure’s 3-dimensional, spherical nucleic acid (SNA™) architecture seeks to unlock the potential of nucleic acid therapeutics in multiple organs. Exicure’s lead programs address diseases from ...

Monday 13th November 2017

Arcus Biosciences

Arcus Biosciences (“Arcus”) is a biotechnology company focused on the discovery and development of innovative cancer immunotherapies. Arcus was founded in 2015 by Terry Rosen and Juan Jaen, the co-founders of Flexus Biosciences, which in February 2015 was acquired by Bristol-Myers Squibb to access Flexus’s IDO inhibitor, which was in preclinical...

Thursday 9th November 2017

Northern Biologics Inc.

Northern Biologics was launched in June 2014 from Blueline Bioscience, a Canadian biotechnology incubator operated by venture capital firm Versant Ventures, in partnership with the University of Toronto and University Health Network’s Princess Margaret Cancer Centre. Headquartered in the MaRS Discovery District of Toronto, the company is developing a ...

Neuronax SAS

NEURONAX is a privately-held biopharmaceutical company focusing on the development and discovery of therapeutic approaches to treat central nervous system disorders. Combining an expertise in the development of candidate-drugs and know-how in cell-based assays, NEURONAX builds a well balanced portfolio of compounds and technologies implied in neurorepair. Moreover, the original platform of NEURON...

Wednesday 8th November 2017

DisperSol Technologies LLC

DisperSol is an innovator in the formulation development and manufacture of pharmaceutical drugs. DisperSol’s KinetiSol® technology has dramatically improved the effectiveness of drugs by superior enhancement of drug loading, solubility, permeability and bioavailability relative to other technologies. This has enabled the improvement of approved dr...

iVeena Delivery Systems, Inc.

iVeena Delivery Systems, Inc. (iVeena) is a privately held biopharmaceutical company that develops innovative ophthalmology products. iVeena utilizes a proprietary intracapsular drug delivery platform to enhance a medication’s ocular bioavailability to anterior and posterior eye segments. The lead product delivers dexamethasone to treat post-cataract ...

Tuesday 7th November 2017

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary hydrogel-based formulation technology. Ocular Therapeutix’s lead product candidate, DEXTENZA™ (dexamethasone insert) 0.4 mg for intracanalicular ...

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fully-human monoclonal antibody being developed for female malignancies. The OncoResponse discovery engine is working to increase the success rate of cancer immunotherapies by ident...

EOC Pharma Group

EOC is a fast-growing, Shanghai-based biopharmaceutical company that is focused on the in-licensing of innovative global oncology products, and developing, manufacturing and commercializing them for the China market. The Company is building a fully integrated manufacturing, development and commercialization platform, and has a pipeline of six novel products ...

Vizient Inc.

Vizient, Inc., the largest member-driven health care performance improvement company in the country, provides innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership base includes academic medical centers, pediatric facilities, community hospitals,...

PointClickCare Technologies Inc.

PointClickCare Technologies Inc. is advancing senior care by enabling long-term and post-acute care (LTPAC) and senior living providers to achieve the business results that matter – enriching the quality of life for their residents, improving financial and operational health, and mitigating risk. Recognized by Forbes as one of the Top 100 Private Clou...

Wednesday 1st November 2017

Remedy Partners

Remedy Partners delivers software and services that enable payers, employers and at-risk providers to organize and finance healthcare delivery around a patient's episode of care. For healthcare providers, Remedy Partners’ software, analytics and administrative services support bundled payment contracts with Medicare and commercial insurers, principall...

Tuesday 31st October 2017

NeoMatrix Therapeutics, Inc.

NeoMatrix Therapeutics, Inc. www.neomatrixtx.com is a clinical-stage company dedicated to discovering and developing novel therapeutic agents for the treatment of serious burn injuries. The Company was founded by Richard A. Clark, M.D., Professor of Dermatology, Biomedical Engineering, and Medicine at Stony Brook University, and has its headquarters in the...

Monday 30th October 2017

MedX Health Corp.

MedX Health Corp. is an exciting, innovative enterprise that is changing the way people heal. With a leadership team comprised of medical technology experts, MedX is designing, developing and manufacturing FDA approved, state-of-the-art low level laser phototherapy and light therapy devices that provide safe, reliable and cost-effective alternatives to traditional medicine and drug therapies. Meet...

Friday 27th October 2017

BEFORE Brands, Inc.

The immune system: part soldier, part sentinel. An essential balance, perfected by time but increasingly disrupted by modern living. BEFORE Brands™ is developing edible products to support this critical duality, beginning in healthy infants before problems arise. Our products use our proprietary Early Adaptive Training™ blend of whole food proteins & ...

Lin BioScience, Inc.

Lin BioScience, Inc. is a drug development company specializing in innovative therapies for diseases with unmet medical needs. Lin BioScience's diverse pipeline consists of first-in-class drugs aimed at treating life-threatening or disabling diseases in ophthalmology, oncology and metabolic diseases.

Thursday 26th October 2017

GeneCentric Therapeutics

GeneCentric Therapeutics is applying proprietary technology to identify drug responder populations that enable development of precision medicine drugs and improve patient outcomes. Our approach applies the Cancer Subtype Platform (CSP®) to parse complex tumor biology into genomic signatures revealing high-resolution cancer subtypes, with potential as un...

Shaun T

Shaun T is a world-renowned health and fitness expert, TV host, motivator and creator of the best-selling fitness programs including INSANITY, HIP HOP ABS, FOCUS T25, INSANITY MAX:30 and CIZE. In June 2017, Shaun T released his new program, SHAUN WEEK, which was another mega-hit, reaching 1 million downloads in 6 days. He has hosted several primetime TV se...

Tuesday 24th October 2017

JDRF T1D Fund

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund accelerating life changing solutions to treat, prevent, and cure type 1 diabetes (T1D) through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, corporations and foundations, the T1D Fund seeks to attract the private in...

Thursday 19th October 2017

Quantros

Quantros is a leading healthcare software and services provider of data management, decision support analytics, and clinical business intelligence solutions for the healthcare industry in areas of safety and risk management, quality and performance improvement, outcomes monitoring and accreditation and compliance. For more information about Quantros, visit www.quantros.com.

Wednesday 18th October 2017

Reemo Health

Reemo is a health and safety technology platform designed to empower caregivers with actionable insights to improve the quality of life for seniors and patients. Through the use of wearables and near real-time data and analytics, Reemo technology strengthens the connection between wearers and families, while helping senior living and healthcare organizatio...


More From BioPortfolio on "University Eastern Finland Release Antiulcer Drugs Increase Risk"

Quick Search
Advertisement
 

Corporate Database Quicklinks